but fewer than half of all diabetic patients are assessed annually for retinopathy, despite the high frequency of this complication.
Wake Forest, NC (PRWEB) February 12, 2009
Valley Endocrinology and Research Center has selected Retasure™ by Digital Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics.
Valley Endocrinology and Research Center provides care to the residents of Central California Valley and surrounding communities. Valley Endocrine and Research delivers personalized care and health-related services consistent with the highest quality medical and ethical standards to improve the health status of the people they serve.
"A picture is worth a thousand words" states Dr. Paul Norwood, Director of Valley Endocrinology and Research Center, "I received notice from Blue Cross that less than 30% of my diabetic patients had received their annual eye exam. Retasure will enable me to be 100% compliant with my diabetic retinal health assessments. Many of my patients do not visit with an eye care professional because it's inconvenient and diabetic retinopathy many times is asymptomatic. I can now provide them with a retinal health assessment during one of their routine office visits." says Norwood. I review the retinal photographs with the patient from my laptop at the end of their visit. They feel and truly are receiving an extra value for their visits."
The Retasure™ solution developed by Digital Healthcare provides a simple, affordable, and non-invasive solution that allows physicians to capture their patients' retinal images during a three to five minute procedure. Images are transmitted over a secure network to an accredited reading center. Scott Sanner, Senior Vice President of North American Operations for Digital Healthcare agrees. "Retasure ™ in the primary care setting improves the chances of prevention of unnecessary sight loss. The National Eye Institute states that diabetic retinopathy is the leading cause of blindness among working age adults in America," he says, "but fewer than half of all diabetic patients are assessed annually for retinopathy, despite the high frequency of this complication."
Digital Healthcare's Retasure solution offers several advantages for primary care and endocrinologist physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation; and it obtains exceptionally high-quality digital images of the retina. This FDA-approved technology is used by a broad range of doctors and facilities throughout the United States and the United Kingdom, including leading hospitals and research centers, primary care groups, private ophthalmology and optometry groups, family practice residency centers, and internal, multi-specialty and endocrinology groups.
For additional information, please visit http://www.retasure.com